Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Risalto Health is a digital health company that provides an AI-powered platform designed to transform musculoskeletal (MSK) care. The company's technology analyzes healthcare data to identify the most effective, evidence-based care pathways for patients suffering from back, neck, and joint pain. By connecting members with high-quality providers and personalized treatment plans, Risalto aims to improve patient outcomes while reducing the total cost of care for employers and health plans. In 2022, the company was acquired by Transcarent to integrate its MSK solutions into a broader health and care platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Risalto Health.